Overexpression of ErbB2 receptor inhibits IGF-I-induced Shc-MAPK signaling pathway in breast cancer cells

By Lu Y.   Zi X.   Zhao Y.   Pollak M.  

Biochemical and Biophysical Research Communications, Vol. 313, Iss. 3, 2004-01 ,pp. : 709-715

Elsevier

Access to resources Recommend Favorite

Enhanced Drug Resistance in Cells Coexpressing ErbB2 with EGF Receptor or ErbB3

By Chen X.   Yeung T.K.   Wang Z.  

Biochemical and Biophysical Research Communications, Vol. 277, Iss. 3, 2000-11 ,pp. : 757-763

Elsevier

Access to resources Recommend Favorite

Neuregulin Induces the Rapid Association of Focal Adhesion Kinase with the erbB2–erbB3 Receptor Complex in Schwann Cells

By Vartanian T.   Goodearl A.   Lefebvre S.   Park S-K.   Fischbach G.  

Biochemical and Biophysical Research Communications, Vol. 271, Iss. 2, 2000-05 ,pp. : 414-417

Elsevier

Access to resources Recommend Favorite

C-Src Activation by ErbB2 Leads to Attachment-Independent Growth of Human Breast Epithelial Cells

By Sheffield L.G.  

Biochemical and Biophysical Research Communications, Vol. 250, Iss. 1, 1998-09 ,pp. : 27-31

Elsevier

Access to resources Recommend Favorite

Inhibition of the erbB-2 Tyrosine Kinase Receptor in Breast Cancer Cells by Phosphoromonothioate and Phosphorodithioate Antisense Oligonucleotides

By Vaughn James P.   Demirdji Samuel   Mills Jeffrey K.   Caruthers Marvin H.   Iglehart J. Dirk   Marks Jeffrey R.  

Nucleic Acids Research, Vol. 24, Iss. 22, 1996-11 ,pp. : 4558-4564

Oxford University Press

Access to resources Recommend Favorite